Posted Tuesday June 23, 2020

Reaction Cycle

New mechanism and drugs to boost immune system, potentially treat COVID-19 discovered

A new mechanism to greatly boost the immune defense system with a specific class of drugs may be the key to treating COVID-19 and other diseases or viruses, such as HIV and cancer.

The research is grounded in the discovery of a new mechanism that amplifies the reaction cycle of the human immune defense system.

“This discovery can have a huge impact in the treatment of many diseases and viruses and importantly right now, COVID-19,” said Professor Qing-Bin Lu, lead researcher on the study. “With this new knowledge, we hope to be able to greatly boost the efficacy of the immune system to help it fight aggressive viruses and diseases with new potent compounds to outperform drugs that have some very serious side-effects.”

Lu discovered a new signaling pathway that functions in a delicate balance with a known nitrogen-oxide pathway within the reaction cycle of the immune system. The new pathway triggers the reaction cycle which ignites the immune defense. With this knowledge, Lu has identified a class of drugs that acts on the new pathway, stimulating it to fight off illness in a much safer and more effective way.

“We have substantially increased the fundamental understanding about the immune defense with this discovery,” said Lu. “The research shows that the antiviral effect via the reaction cycle can be amplified by 100,000-fold, resembling the reactions causing the large ozone hole in the atmosphere. It’s very exciting to begin moving into the next phase of research on this discovery and to provide another possible treatment for viral diseases such as HIV and COVID-19.”

 is distributed twice weekly; Tuesday and Thursday

Not a Subscriber? Receive more articles on business issues
Sent directly to your email in-box.

contact us

Publisher is Exchange Business Communication Inc.
Email Publisher

ISSN 0824-45
Copyright, 2020

Share Your Story: pressrelease @
Expand Your Reach:
advertise @
Publisher: Exchange Business Communication Inc., PO Box 248, Waterloo, Ontario, Canada
Email Editor

Content published on this site represents the opinion of the individual, organization and/or source provider. is a online daily journal of Exchange Business Communication Inc. (1997) Publishers of Exchange Magazine est. 1983. Privacy Policy. Copyright of Exchange produced editorial is the copyright of Exchange Business Communications Inc. 2020. Submitted editorials, comments and releases are copyright of respective source(s).